Progressive multifocal leukoencephalopathy in myelodysplastic syndrome involving pure red cell aplasia

Intern Med. 2010;49(21):2347-52. doi: 10.2169/internalmedicine.49.4081. Epub 2010 Nov 1.

Abstract

Progressive multifocal leukoencephalopathy (PML) is a rare and fatal demyelinating disease of the central nervous system caused by JC polyomavirus (JCV) reactivation in an immunocompromised host. We describe a case of PML in a 76-year-old woman with myelodysplastic syndrome, who had been treated with azathioprine for a pure red cell aplasia-like condition. PML was diagnosed based on the neurologic symptoms, the magnetic resonance imaging patterns and the detection of JCV DNA in the cerebrospinal fluid. She died ten months after the diagnosis. An autopsy confirmed the diagnosis, and JCV DNA was detected in the cerebrum. Azathioprine might have triggered PML.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Azathioprine / adverse effects
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Leukoencephalopathy, Progressive Multifocal / complications
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / diagnosis*
  • Red-Cell Aplasia, Pure / complications
  • Red-Cell Aplasia, Pure / diagnosis*

Substances

  • Immunosuppressive Agents
  • Azathioprine